###begin article-title 0
Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia
###end article-title 0
###begin p 1
Conceived and designed the experiments: VP PR. Performed the experiments: VP EPD SG. Analyzed the data: VP EPD SG FA ML AH. Contributed reagents/materials/analysis tools: FA ML AH. Wrote the paper: PR.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Friedreich ataxia originates from a decrease in mitochondrial frataxin, which causes the death of a subset of neurons. The biochemical hallmarks of the disease include low activity of the iron sulfur cluster-containing proteins (ISP) and impairment of antioxidant defense mechanisms that may play a major role in disease progression.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 125 133 <span type="species:ncbi:9606">patients</span>
We thus investigated signaling pathways involved in antioxidant defense mechanisms. We showed that cultured fibroblasts from patients with Friedreich ataxia exhibited hypersensitivity to oxidative insults because of an impairment in the Nrf2 signaling pathway, which led to faulty induction of antioxidant enzymes. This impairment originated from previously reported actin remodeling by hydrogen peroxide.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Thus, the defective machinery for ISP synthesis by causing mitochondrial iron dysmetabolism increases hydrogen peroxide production that accounts for the increased susceptibility to oxidative stress.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 210 213 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Tzagoloff1">[1]</xref>
###xml 409 412 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rustin1">[2]</xref>
###xml 550 553 550 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Han1">[3]</xref>
###xml 761 764 761 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Koehler1">[4]</xref>
###xml 863 866 863 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Droge1">[5]</xref>
###xml 977 981 977 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 1009 1010 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1115 1118 1115 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rustin1">[2]</xref>
###xml 1264 1267 1264 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Wallace1">[6]</xref>
###xml 1535 1543 1535 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1543 1546 1543 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-ChantrelGroussard1">[7]</xref>
###xml 1551 1558 1551 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1558 1561 1558 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rustin2">[8]</xref>
###xml 1563 1566 1563 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-VazquezManrique1">[9]</xref>
###xml 1568 1572 1568 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Llorens1">[10]</xref>
###xml 1768 1772 1768 1772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rustin3">[11]</xref>
###xml 1774 1778 1774 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-DiProspero1">[12]</xref>
Mitochondria are the main site of molecular oxygen utilization in cells. The divalent reduction of oxygen by the respiratory chain is tightly coupled to ATP synthesis by the oxidative phosphorylation machinery [1]. However, monovalent reduction of a small proportion of the available oxygen, which produces superoxide anions, occurs in association with the transfer of electrons through the respiratory chain [2]. During this process, superoxides may be released on both sides of the inner mitochondrial membrane, depending on their production sites [3]. They are subsequently handled by the superoxide dismutases (SODs) present in mitochondria (manganese-dependent SOD in the matrix compartment and copper, zinc-dependent SOD in the intermembrane compartment) [4]. Under basal conditions, progression through the cell cycle is dependent on superoxide production [5]. However, overproduction of superoxides due to abnormal reduction of key components of the respiratory chain (i.e., ubiquinone and cytochrome b) or to impairment of antioxidant defenses adversely affects various cellular processes and constituents [2]. Disturbances in either respiratory chain or cellular defenses are being incriminated in an increasing number of acquired and inherited diseases [6]. In this study, we used Friedreich ataxia (FRDA) as a paradigm to investigate the mechanisms involved in impaired cellular responses to mitochondrial oxidative insults. The increased susceptibility to oxidative stress that characterizes FRDA has been documented both in vitro[7] and in vivo[8], [9], [10]. Progression of the cardiac hypertrophy and of some of the neurological disorders can be slowed by treatment with idebenone, a short-chain ubiquinone homologue with potent antioxidant properties [11], [12].
###end p 9
###begin p 10
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Harding1">[13]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Campuzano1">[14]</xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Campuzano2">[15]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rotig1">[16]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Muhlenhoff1">[17]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Isaya1">[18]</xref>
###xml 887 891 887 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rotig1">[16]</xref>
###xml 998 1002 998 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Lill1">[19]</xref>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
FRDA is a neurodegenerative condition responsible for cerebellar ataxia and life-threatening cardiomyopathy. Glucose intolerance or diabetes develops in some patients [13]. More than 95% of patients are homozygous for large expansions (60 to 2000) of a GAA triplet-repeat sequence within the first intron of the gene for frataxin, a 210-amino acid protein found in the mitochondrial matrix [14]. The expansion impedes the transcription of the gene and reduces frataxin levels to a few percentage points of normal [15]. Affected tissues are deficient in iron-sulfur cluster (ISC) proteins [16], whose assembly is impaired as a result of inadequate handling of iron [17], [18]. ISC deficiency results in profound deficiencies in the mitochondrial respiratory chain complexes I, II, and III and of the Krebs cycle enzyme aconitase, all of which require ISCs for electron transfer catalysis [16]. Since ISCs synthesized in the mitochondria are subsequently distributed to the various cell compartments [19], the deficiency is not restricted to mitochondrial enzymes but instead affects non-mitochondrial proteins also.
###end p 10
###begin p 11
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rotig1">[16]</xref>
###xml 416 419 416 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-ChantrelGroussard1">[7]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Wong1">[20]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Pastore1">[21]</xref>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Auchere1">[22]</xref>
###xml 682 683 682 683 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sc>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Jiralerspong1">[23]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Dassa1">[24]</xref>
###xml 1123 1127 1123 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Itoh1">[25]</xref>
###xml 1320 1324 1320 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Zhang1">[26]</xref>
###xml 1675 1679 1675 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Harding1">[13]</xref>
###xml 1889 1893 1889 1893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Zhu1">[27]</xref>
###xml 1895 1899 1895 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Yang1">[28]</xref>
###xml 286 294 <span type="species:ncbi:9606">patients</span>
###xml 778 783 <span type="species:ncbi:9606">human</span>
Several tissues (e.g., skeletal muscle) and cells (e.g., skin fibroblasts and circulating lymphocytes) seem able to cope with low frataxin levels and to synthesize enough ISCs to ensure normal production of respiratory chain complexes and aconitase [16]. Nevertheless, fibroblasts from patients with FRDA have impaired responses to oxidative insults, whether endogenous (mitochondrial ATPase blockade by oligomycin) [7] or exogenous (added hydrogen peroxide) [20]. FRDA fibroblasts exhibit actin stress fiber abnormalities [21] and are deficient in glutathione [22]. Previous attempts to determine why these cells are hypersensitive to oxidative stress were unsuccessful. Faulty NF-kB-dependent signaling of antioxidant defenses was ruled out [23]. We recently established that human fibroblasts harboring the ATPase 6 NARP mutation activated the Nrf2-dependent Phase II antioxidant pathway [24]. Under basal conditions, the transcription factor Nrf2 (nuclear factor-erythroid 2-related factor 2) is sequestered in the cytosol, where its Neh2 domain binds to the Kelch domain of the Keap1 protein tethered to actin bundles [25]. These bundles, called actin stress fibers, are found in the center of the cytoplasm and periphery of the nucleus. Cul3-dependent ubiquitination of Nrf2 leads to degradation by the proteasome [26]. When oxidative modification of one of the Keap1 cysteines occurs, Nrf2 escapes from this proteolytic pathway. Phosphorylated Nrf2 then translocates to the nucleus, where it dimerizes with a small Maf protein and binds to the cis-acting antioxidant responsive element (ARE) DNA sequences of Phase II antioxidant genes, activating their transcription [13]. These genes encode the SODs, catalase, glutathione, glutathione reductase (GRed), glutathione-S-transferase (GST), glutamate-cysteine ligase catalytic subunit (GCLC), and NADH quinone oxidoreductase 1 (NQO1) [27], [28].
###end p 11
###begin p 12
###xml 147 155 <span type="species:ncbi:9606">patients</span>
Here, we investigated the mechanism underlying the increased sensitivity to oxidative stress of frataxin-depleted cells (cultured fibroblasts from patients with FRDA and neuroblastomata-derived SKNAS cells). The Nrf2-dependent signaling pathway was found to be defective. The phenotype associated with the Nrf2-signaling defect was corrected by the catalase mimetic Euk134, emphasizing the key role for the cellular hydrogen peroxide content.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Increased sensitivity of FRDA cultured fibroblasts to oxidative stress
###end title 14
###begin p 15
###xml 220 227 220 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004253-t001">Table 1</xref>
###xml 337 346 337 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g001">Figure 1b</xref>
###xml 1091 1095 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Lillig1">[29]</xref>
###xml 1097 1101 1097 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Berndt1">[30]</xref>
###xml 1217 1226 1217 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004253.s001">Figure S1</xref>
###xml 1244 1251 1244 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004253.s003">Text S1</xref>
###xml 743 751 <span type="species:ncbi:9606">patients</span>
SOD levels were moderately but consistently elevated and GSH levels were decreased in severely frataxin-depleted FRDA cultured fibroblasts under basal culture conditions, indicating abnormally high antioxidant activity (Table 1). Cell respiration was normal, and oxidative activity was tightly controlled by the phosphorylation process (Figure 1b). No decreases were found in the activities of the respiratory chain complexes (CI to CV). There was no superoxide overproduction by the respiratory chain, as indicated by the antimycin-resistant cytochrome c reductase activity measured under highly reducing conditions (not shown). Aconitase, an ISC-containing enzyme whose activity is diminished in affected tissues (heart and brain) from FRDA patients, showed similar levels of activity in FRDA and control fibroblasts. Finally, we investigated the glutaredoxin 2 (Grx2) protein, which contains an ISC and protects against oxidative damage by helping to maintain glutathione homeostasis. The ISC stabilizes an inactive form of Grx2, which becomes active upon oxidative disruption of the ISC [29], [30]. We found no significant changes in the Grx2 expression profile between FRDA and control fibroblasts (Supplemental Figure S1 and Supplemental Text S1 for experimental conditions).
###end p 15
###begin title 16
Effect of frataxin depletion on oxidative stress resistance, oxidative properties, and actin-Nrf2 signaling pathway status in cultured skin fibroblasts.
###end title 16
###begin p 17
###xml 299 300 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 313 314 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 745 746 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 772 773 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1359 1366 1353 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 30 37 <span type="species:ncbi:9606">patient</span>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
###xml 393 400 <span type="species:ncbi:9606">patient</span>
###xml 447 455 <span type="species:ncbi:9606">patients</span>
###xml 612 620 <span type="species:ncbi:9606">patients</span>
###xml 970 977 <span type="species:ncbi:9606">patient</span>
###xml 1065 1072 <span type="species:ncbi:9606">patient</span>
###xml 1174 1181 <span type="species:ncbi:9606">patient</span>
###xml 1293 1300 <span type="species:ncbi:9606">patient</span>
A. Sensitivity of control and patient cells to oligomycin (30 microM for 4 days). Cells were harvested at 24-hour intervals and live cells were counted. The proportion of surviving cells was significantly different between controls and patients (ANOVA p<0.01). Significant differences were noted (**p<0.01 and ***p<0.001). Values are means+/-1 SEM. Open and dark symbols represent control and patient cells, respectively. Filled squares represent patients. B. Effect of frataxin depletion on cell oxidative properties. Under basal conditions, respiration rates were similar between fibroblasts from controls and patients. Adding oligomycin caused greater than 80% inhibition in both cell types. Uncoupled respiration measured in the presence of m-Cl-CCP (carbonyl cyanide m-chlorophenylhydrazone) decreased progressively when digitonin was added to induce cell permeabilization. Malonate-sensitive mitochondrial succinate oxidation was not different between control and patient cells. Numbers along the traces are nmol/min/mg protein. C. Nrf2/Keap1 localization in patient and control fibroblasts. Labeling of Nrf2, actin (Phal), and Keap1 proteins in control (a, b, c) and patient (e, f, g) fibroblasts, showing disorganization of the actin network and abnormal location of Nrf2 and Keap1 in patient fibroblasts. Experimental procedures are described in the methods section.
###end p 17
###begin title 18
###xml 50 58 <span type="species:ncbi:9606">patients</span>
Chronic abnormal redox status in fibroblasts from patients with Friedreich ataxia.
###end title 18
###begin p 19
###xml 44 51 44 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
Experimental conditions as described in the methods section.
###end p 19
###begin p 20
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">***</sup>
###xml 14 15 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 and ***p<0.001 respectively.
###end p 20
###begin p 21
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Geromel1">[31]</xref>
###xml 204 213 204 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g001">Figure 1A</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Wong1">[20]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Jauslin1">[32]</xref>
###xml 459 462 459 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-ChantrelGroussard1">[7]</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Jiralerspong1">[23]</xref>
Whereas FRDA fibroblasts proliferate normally under basal conditions, they are oversensitive to the endogenous oxidative insult that results from oligomycin-induced blockade of mitochondrial ATPase [31] (Figure 1A). Similarly, frataxin-depleted cells are oversensitive to endogenous and exogenous oxidative insults [20], [32]. We and others have ascribed this increased sensitivity to impaired induction of antioxidant enzymes in response to oxidative stress [7], [23].
###end p 21
###begin title 22
Abnormal location of the Nrf2 transcription factor in FRDA cultured fibroblasts
###end title 22
###begin p 23
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Zhu1">[27]</xref>
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Zhu2">[33]</xref>
###xml 197 213 197 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g001">Figure 1Ca and b</xref>
###xml 272 282 272 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g001">Figure 1Cc</xref>
###xml 375 385 375 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g001">Figure 1Cd</xref>
###xml 443 453 443 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g001">Figure 1Ce</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Pastore1">[21]</xref>
###xml 606 616 606 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g001">Figure 1Cf</xref>
Transcription of inducible antioxidants is controlled chiefly by the Nrf2 transcription factor [27], [33]. We found that Nrf2 in control cells was bound to phalloidin-reactive actin stress fibers (Figure 1Ca and b), which also tethered the redox-sensitive Keap-1 protein (Figure 1Cc). In contrast, Nrf2 was not associated with any filamentous structures in FRDA fibroblasts (Figure 1Cd), whose actin stress fibers were abnormally distributed (Figure 1Ce), being found mainly in the cell periphery as previously reported [21]. Finally, Keap1 was not associated with actin stress fibers in FRDA fibroblasts (Figure 1Cf).
###end p 23
###begin title 24
Nrf2 fails to translocate to FRDA cultured fibroblast nuclei in response to oxidative stress
###end title 24
###begin p 25
###xml 14 15 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Drobinskaya1">[34]</xref>
###xml 251 252 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Kahl1">[35]</xref>
###xml 432 433 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 543 556 543 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g002">Figure 2A a&#8211;c</xref>
###xml 624 637 624 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g002">Figure 2A d&#8211;f</xref>
###xml 764 768 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Byrne1">[36]</xref>
###xml 845 849 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Huang1">[37]</xref>
Oligomycin or tBHQ was used to induce endogenous or exogenous oxidative stress, respectively. Oligomycin inhibits the enzyme ATPase, thus causing over reduction of the mitochondrial quinone pool, which in turn leads to superoxide overproduction [34]; tBHQ undergoes redox cycling either by cellular quinone reductases or via autooxidation reactions, the main end product being hydrogen peroxide [35]. Upon exposure to oligomycin or tBHQ, Nrf2 in control cells was released from the actin stress fibers then translocated chiefly to the nuclei (Figure 2A a-c). Nuclear translocation of Nrf2 in FRDA fibroblasts did not occur (Figure 2A d-f). Interestingly enough, neither activation of the Phosphatidyl Inositol 3 kinase (PI3 kinase) by compound 48/80 (2 microg/ml) [36] nor Protein Kinase C (PKC) by phorbol 12-myristate 13-acetate (5 microg/ml) [37] did restore the capacity of a Nrf2 nuclear translocation in FRDA fibroblasts upon an oxidative stress (oligomycin treatment; not shown).
###end p 25
###begin title 26
###xml 45 52 <span type="species:ncbi:9606">patient</span>
Nrf2 location and amount in control and FRDA patient fibroblasts under basal and oxidative stress conditions.
###end title 26
###begin p 27
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 533 534 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 926 927 918 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 939 940 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1019 1026 1009 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 46 53 <span type="species:ncbi:9606">patient</span>
###xml 226 233 <span type="species:ncbi:9606">patient</span>
###xml 416 423 <span type="species:ncbi:9606">patient</span>
###xml 862 869 <span type="species:ncbi:9606">patient</span>
A. Nrf2 localization in control (a, b, c) and patient (d, e, f) fibroblasts under basal conditions (a, d) or after treatment with oligomycin (b, e) or tBHQ (c, f). Nuclear Nrf2 translocation occurred in control cells, but not patient cells, after oligomycin or tBHQ treatment. B. Western blots of cytoplasmic (a; 40 microg/lane protein) and nuclear (b; 60 microg/lane protein) fractions from control (lanes 1-3) and patient (lanes 4-6) fibroblasts under basal conditions (lane 1, 4), after oligomycin treatment (lane 2, 5), or after tBHQ treatment (lane 3, 6). The specificity of the 100 kDa band was confirmed using two antibodies (H-300 and C-20). Fraction purity (d) was assessed by labeling with GAPDH (cytoplasm) and Histone H1 antibody (nuclei). C. Nrf2 content relative to GAPDH and Histone H1 contents in cytoplasmic and nuclear fractions of control and patient fibroblasts. Asterisks denote significant differences (*p<0.05 and **p<0.01). Values are means+/-1 SEM. Experimental procedures are described in the methods section.
###end p 27
###begin p 28
###xml 129 138 129 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g002">Figure 2B</xref>
###xml 272 273 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 278 287 278 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g002">Figure 2B</xref>
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 505 514 505 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g002">Figure 2C</xref>
Next, we performed Western blot analyses of nuclei-enriched fractions and cytoplasmic fractions of control and FRDA fibroblasts (Figure 2B). In the cytoplasmic fractions of control and FRDA fibroblasts, Nrf2 content increased 2-fold to 4-fold in response to oligomycin or tBHQ (Figure 2B). In the nuclei-enriched fraction of control cells, Nrf2 increased 4-fold in response to oligomycin and 8-fold in response to tBHQ. Far smaller Nrf2 increases were seen in the nuclei-enriched fractions of FRDA cells (Figure 2C).
###end p 28
###begin title 29
Decreased expression of Nrf2-targeted genes in FRDA cultured fibroblasts
###end title 29
###begin p 30
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 468 477 468 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g003">Figure 3A</xref>
###xml 616 617 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 793 802 793 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g003">Figure 3B</xref>
The failure of Nrf2 to translocate to the nucleus in FRDA cells exposed to oxidative stress prompted us to investigate the expression of genes controlled by Nrf2. In control fibroblasts, tBHQ led to greater than 10-fold increases in catalase and glutathione-S-transferase subunit 1 (GSTP1) transcripts, a 5-fold increase in NADH quinone oxidoreductase (NQO1) transcript, and virtually no increases in copper-zinc (Sod1)- or manganese (Sod2)-dependent SOD transcripts (Figure 3A). In FRDA cells, the increases were far smaller; most notably, neither catalase nor GSTP1 transcripts increased noticeably in response to tBHQ. Oligomycin treatment of control cells caused large increases in Sod2, catalase, and GSTP1 transcripts; whereas Sod1 and NQO1 transcripts were not substantially increased (Figure 3B). None of these phase II antioxidant enzymes increased in FRDA cells exposed to oligomycin.
###end p 30
###begin title 31
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 67 74 <span type="species:ncbi:9606">patient</span>
Induction of phase II antioxidants mediated by Nrf2 in control and patient fibroblasts treated with tBHQ or oligomycin.
###end title 31
###begin p 32
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 183 190 181 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
Transcription induced by tBHQ (A) or oligomycin (B). Significant differences were noted (*p<0.05 and **p<0.01). Values are means+/-1 SEM. Experimental procedures are described in the methods section.
###end p 32
###begin title 33
Frataxin-depleted SKNAS cells exhibit the FRDA cell phenotype
###end title 33
###begin p 34
###xml 425 434 425 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g004">Figure 4A</xref>
###xml 516 525 516 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g004">Figure 4B</xref>
The disruption of the Nrf2-signaling pathway in FRDA fibroblasts suggested a mechanism for the hypersensitivity of frataxin-depleted cells to oxidative stress. However, neurons, not fibroblasts, are selectively targeted in Friedreich ataxia. Therefore, we studied neuroblastoma-derived cell lines (SKNAS), using shRNA to silence frataxin. Immunohistochemistry showed severe frataxin-protein depletion in shRNA-treated cells (Figure 4A). The amount of frataxin in these cells was similar to that in FRDA fibroblasts (Figure 4B).
###end p 34
###begin title 35
Frataxin-depleted SKNAS cells.
###end title 35
###begin p 36
###xml 428 429 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 958 959 958 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1006 1007 1006 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1021 1022 1021 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1102 1109 1100 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 231 238 <span type="species:ncbi:9606">patient</span>
A. Anti-frataxin antibody produced strong mitochondrial labeling in control SKNAS cells (a) and severely reduced labeling in SKNAS cells treated with frataxin-targeted shRNA (shRNAFra SKNAS cells) (b). B. Residual frataxin mRNA in patient fibroblasts and shRNAFra SKNAS cells compared to control cells. C. Actin and Nrf2 in control (a, c, e, g) and shRNAFra (b, d, f, h) SKNAS cells under basal conditions (a, b, c, d) or after tBHQ treatment (e, f, g, h). Actin staining with phalloidin (Phal) shows disorganization of the actin stress fibers in shRNAFra SKNAS cells (a) compared to control SKNAS cells (b), in keeping with the results in fibroblasts. Nrf2 labeling produced similar abundant staining of the cytoplasm of both control SKNAS cells (c) and shRNAFra SKNAS cells (d). Nuclear translocation of Nrf2 occurs in control SKNAS cells (e, g) but not in shRNAFra SKNAS cells. D. Induction of Phase II antioxidants in SKNAS cells using oligomycin (a) or tBHQ (b). Significant differences were noted (**p<0.01 and *** p<0.001). Values are means+/-1 SEM. Experimental procedures are described in the methods section.
###end p 36
###begin p 37
###xml 126 135 126 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g004">Figure 4C</xref>
###xml 236 246 236 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g004">Figure 4Ca</xref>
###xml 452 462 452 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g004">Figure 4Cb</xref>
###xml 537 553 537 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g004">Figure 4Cc and d</xref>
Next, we investigated the organization of actin stress fibers and the location of Nrf2 under basal conditions in SKNAS cells (Figure 4C). Actin stress fibers were visualized by phalloidin labeling in SKNAS cells under basal conditions (Figure 4Ca). Nrf2 labeling, in contrast, did not show the filamentous structures observed in fibroblasts. Frataxin-depleted SKNAS cells exhibited actin network reorganization similar to that observed in fibroblasts (Figure 4Cb). After Nrf2 staining, they were nearly identical to control SKNAS cells (Figure 4Cc and d).
###end p 37
###begin p 38
###xml 8 9 8 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 121 137 121 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g004">Figure 4Ce and g</xref>
###xml 178 194 178 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g004">Figure 4Cf and h</xref>
We used tBHQ to induce oxidative stress of SKNAS cells. Nuclear translocation of Nrf2 occurred with control SKNAS cells (Figure 4Ce and g) but not frataxin-depleted SKNAS cells (Figure 4Cf and h). Similar results were obtained when control and frataxin-depleted SKNAS cells were treated with oligomycin (not shown). Thus, as with FRDA fibroblasts, frataxin depletion was associated with impairment of the Nrf2 signaling pathway in SKNAS cells.
###end p 38
###begin p 39
###xml 193 203 193 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g004">Figure 4Da</xref>
###xml 208 209 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 214 224 214 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g004">Figure 4Db</xref>
Finally, we investigated whether the transcription of Nrf2-targeted genes was impaired in frataxin-depleted SKNAS cells exposed to oxidative stress. Treating control SKNAS cells by oligomycin (Figure 4Da) or tBHQ (Figure 4Db) resulted in the accumulation of NQO1, glutathione reductase (GRed) and GSTP1, to variable degrees. None of these transcripts increased in frataxin-depleted SKNAS cells exposed to oxidative stress.
###end p 39
###begin title 40
A catalase mimetic restores the Nrf2 response to oxidative stress
###end title 40
###begin p 41
###xml 165 172 165 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004253-t001">Table 1</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Gianello1">[38]</xref>
###xml 565 582 565 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g005">Figure 5A a and b</xref>
###xml 634 651 634 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g005">Figure 5A c and d</xref>
###xml 690 698 690 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004253.s002">Table S1</xref>
Our finding that frataxin-depleted FRDA fibroblasts exhibited a small but consistent increase in peroxide production, in keeping with the higher basal level of SOD (Table 1) led us to investigate the effects of correcting the increased peroxide levels via treatment with the catalase mimetic Euk134. Euk134 is derived from a compound with SOD activity that has been modified to obtain strong catalase activity [38]. Euk134 diffuses freely through the plasma membrane. Euk134 treatment of frataxin-depleted fibroblasts for 24 hours restored the actin stress fibers (Figure 5A a and b) and relocated Nrf2 to the actin filament network (Figure 5A c and d) in a concentration-dependent manner (Table S1). A fraction of the Nrf2 was found in the perinuclear region after Euk134 treatment, resulting in a distinctive perinuclear halo (Fignal 5Ad). These results were not replicated using manganese-tetrakis (4-benzoic acid) porphyrin (MnTBAP) to target superoxides (data not shown) pointing to a specific effect of hydrogen peroxide in the Nrf2 mislocation.
###end p 41
###begin title 42
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Effect of Euk134 on Nrf2 localization under basal conditions and during oxidative stress in fibroblasts from patients with Friedreich ataxia.
###end title 42
###begin p 43
###xml 328 329 324 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 483 484 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 693 700 685 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 747 748 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 110 117 <span type="species:ncbi:9606">patient</span>
###xml 235 242 <span type="species:ncbi:9606">Patient</span>
###xml 588 595 <span type="species:ncbi:9606">patient</span>
A. Staining of actin (a,b) and Nrf2 (c,d) in untreated (a, c) and treated (200 microM Euk134 for 24 h) (b, d) patient fibroblasts. Euk134 restored the normal actin network organization and the location of Nrf2 on the actin bundles. B. Patient fibroblasts under basal conditions (a, d), with oligomycin treatment (b, e), or with tBHQ treatment (c, f) after 24 hours pretreatment with 200 microM Euk134 (d, e, f) or without pretreatment (a, b, c). In pre-treated cells, oligomycin and tBHQ induced massive nuclear translocation of Nrf2. C. Induction of Phase II antioxidants in control and patient fibroblasts treated with oligomycin. Treatments and experimental procedures are described in the methods section. Significant differences were noted (*p<0.05). Values are means+/-1 SEM.
###end p 43
###begin p 44
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 284 294 284 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g005">Figure 5Bd</xref>
###xml 391 407 391 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g005">Figure 5Be and f</xref>
###xml 520 529 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g005">Figure 5C</xref>
###xml 793 794 793 794 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 795 796 795 796 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 798 799 798 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 961 965 961 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Anderson1">[39]</xref>
###xml 921 931 <span type="species:ncbi:7227">Drosophila</span>
We investigated nuclear Nrf2 translocation in Euk134-treated frataxin-depleted fibroblasts in response to endogenous or exogenous oxidative stress induced by oligomycin or tBHQ, respectively. Nrf2 in Euk134-treated fibroblasts was found chiefly in the cytosol under basal conditions (Figure 5Bd). Subjecting these cells to oxidative stress resulted in massive nuclear translocation of Nrf2 (Figure 5Be and f) with marked induction of the Phase II antioxidants Sod2, glutathione reductase, and glutathione-S-transferase (Figure 5C). Thus, the catalase mimetic Euk134 not only relocalized Nrf2 to the actin stress filaments under basal conditions, but also restored the responsiveness of the Nrf2 signaling pathway to superoxides generated by the respiratory chain (oligomycin) or to cytosolic H2O2 (tBHQ). In keeping with this, it has been recently shown that hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia [39].
###end p 44
###begin p 45
###xml 411 419 411 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004253.s002">Table S1</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Pastore1">[21]</xref>
Next, we investigated two other approaches designed to restore Nrf2 to its normal location in FRDA fibroblasts. First, we used desferrioxamine or deferiprone for iron chelation (see Supplemental Text for experimental conditions). Both chelators rapidly induced toxic effects, with early aconitase impairment. Neither chelator substantially affected Nrf2 location under our experimental conditions (Supplemental Table S1). Second, to decrease the amount of intracellular peroxides, we provided either reduced glutathione (10 mM) or its precursors N-acetyl cysteine (10 mM) and reduced glutathione ethyl-ester (10 mM). Glutathione has been reported to restore the actin filament network in FRDA cells [21]. However, the actin network was not restored after 48 hours of treatment, whereas Euk134 under similar conditions caused rapid reorganization of the Nrf2 signaling pathway.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Seznec1">[40]</xref>
Our results shed new light on the response of frataxin-depleted FRDA cells to oxidative stress and provide a rational explanation for the hypersensitivity of these cells to oxidative stress. First, we showed that FRDA cells under basal conditions had a small but consistent elevation in SOD activity and confirmed a reduction in reduced glutathione, indicating that they had to cope with abnormally high levels of superoxides and derived peroxides. These data support the view that frataxin depletion places an increased burden on several antioxidant defense mechanisms under basal conditions. They challenge the recent suggestion [40] that oxidative stress may not be involved in this disease.
###end p 47
###begin p 48
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Hentze1">[41]</xref>
###xml 1092 1096 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Goncalves1">[42]</xref>
###xml 1372 1376 1372 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rustin4">[43]</xref>
###xml 1409 1413 1409 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Anderson1">[39]</xref>
###xml 1415 1419 1415 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Bulteau1">[44]</xref>
###xml 1429 1433 1429 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Babcock1">[45]</xref>
###xml 1435 1439 1435 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Campanella1">[46]</xref>
###xml 711 718 <span type="species:ncbi:9606">patient</span>
Although the increased SOD activity and decreased pool of reduced glutathione suggest increased peroxide production, the antioxidant defense mechanisms of FRDA cells effectively handle this challenge under basal conditions: the cells grow normally, show no increase in apoptotic features, and exhibit normal aconitase activity, which is an exquisitely sensitive marker for oxidative stress [41]. The mechanism by which low frataxin content results in an increased need for antioxidants under basal conditions does not result from a defect in the respiratory chain, which we found normal in frataxin-depleted fibroblasts. Neither has a quantitative abnormality in mitochondrial iron content been demonstrated in patient fibroblasts so far. Qualitative abnormalities are however among the predictable consequences of frataxin depletion with impaired iron chaperoning leading to an increase in iron accessibility and intra mitochondrial iron re location favoring iron reaction with oxygen. Unfortunately, use of iron chelators does not provide a clue to test for oxygen-associated iron toxicity [42]. We showed previously that, although iron chelators protect biological membranes from iron-catalyzed peroxidation (antioxidant effect), they also promote oxidative reactions in the aqueous phase (prooxidant effect), thus merely displacing the target of the oxidative process [43]. However, a role of both oxygen [39], [44] and iron [45], [46] in determining the consequences of frataxin depletion has been demonstrated in a number of models and conditions suggesting that their interaction is actually the critical factor.
###end p 48
###begin p 49
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Pastore1">[21]</xref>
###xml 1174 1178 1174 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Dassa1">[24]</xref>
###xml 1308 1312 1308 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Lo1">[47]</xref>
Another finding from our study was disorganization of the Nrf2-dependent phase II antioxidant-signaling pathway in FRDA cells under basal conditions. The actin stress fibers were abnormal, as previously reported [21], and we found that the Keap1 and Nrf2 proteins were not in their normal location bound to actin. Induction of phase II antioxidants was absent or severely decreased in response to endogenous and exogenous oxidative stress. Disorganization of the Nrf2 pathway provides an explanation for the impaired induction of antioxidants in response to prooxidant compounds that has been found repeatedly in frataxin-depleted cells. This disorganization was not ascribable to abnormal ATP generation by the respiratory chain, since we found that respiration was not different between FRDA fibroblasts and control fibroblasts. Moreover, the restoration of the actin filament network in FRDA cells treated with the catalase mimetic Euk134 ruled out a role for abnormal ATP generation. We recently reported marked activation of the Nrf2 pathway in fibroblasts exhibiting an ATPase6 mutation responsible for mitochondrial superoxide overproduction by the respiratory chain [24]. A phosphoglycerate mutase (PGAM5) tethers a ternary complex containing Keap1 and Nrf2 to the outer membrane of the mitochondria [47], suggesting that a sub-pool of these proteins might be required to trigger a cell response to mitochondrial oxidative stress.
###end p 49
###begin p 50
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
We found that induction of Phase II antioxidants differed after oligomycin and tBHQ exposure. Thus, unknown factors may determine which genes undergo increased transcription mediated by Nrf2.
###end p 50
###begin p 51
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Lill1">[19]</xref>
Frataxin is involved in ISC assembly, thereby regulating mitochondrial iron handling and chaperoning [19]. Our results establish that the Nrf2 pathway plays a crucial role in cells with abnormal mitochondrial iron handling and chaperoning, i.e., frataxin- or Iscu-depleted cells. Interestingly, the hypersensitivity to oxidative stress related to frataxin depletion antedated the development of detectable decreases in iron-sulfur dependent enzyme activities. We carefully investigated the cellular Grx2 content, since the Grx2 ISC may constitute a modular reservoir that might have been affected by a partial and undetected impairment of ISC synthesis. However, Grx2 was not decreased in FRDA cells.
###end p 51
###begin p 52
###xml 198 201 198 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rustin2">[8]</xref>
###xml 764 774 764 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Anderson1">[39]</xref>
###xml 1039 1040 1039 1040 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1041 1042 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 764 774 <span type="species:ncbi:7227">Drosophila</span>
Obviously the existence of feedback-controlled loops between prooxidant and antioxidant components that intimately links oxygen to iron metabolism complicates the identification of the initial step [8]. However, most of the evidence from this study and the literature support a crucial role for hydrogen peroxide. Our finding that a catalase mimetic restored the actin stress fibers and oxidant-induced Nrf2 nuclear translocation in FRDA cells established that hydrogen peroxide was among the early effectors in the toxic cascade of oxidizing reactions. Accordingly, we failed to restore Nrf2 nuclear translocation by activating downstream components of the actin-Nrf2 signaling pathway, such as PI3 kinase or PKC. Similarly, recent results obtained using an FRDA Drosophila model support a key role for hydrogen peroxide in the abnormalities associated with frataxin depletion [39]. Finally, the striking analogy between the cerebellar ataxia resulting from either frataxin depletion or alcohol chronic ingestion suggests that a similar H2O2-dependent actin remodeling hampering anti oxidant defenses in a subset of sensory neurons might well be the actual cause of the progressive cerebellar ataxia rather than the genetically fixed ISP defect.
###end p 52
###begin p 53
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-DiProspero1">[12]</xref>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rustin5">[48]</xref>
###xml 335 343 335 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004253-g006">Figure 6</xref>
###xml 650 654 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Schutz1">[49]</xref>
###xml 656 660 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Nicolakakis1">[50]</xref>
In conclusion, our findings suggest an explanation to the hypersensitivity of FRDA cells to oxidative stress, known to be partially counterbalanced in vivo by treatment with an antioxidant such as idebenone [12], [48]. Impairment of the Nrf2 signaling pathway leads to failure of antioxidant induction in response to oxidative stress (Figure 6) which suggests methods for restoring the ability of frataxin-depleted cells to respond effectively to oxidative stress. In keeping with this, ligand activation of PPARgamma (Peroxisome Proliferator Activated Receptor) by the neuroprotective Pioglitazone, susceptible to increase cell antioxidant defenses [49], [50], may constitute one such method.
###end p 53
###begin title 54
###xml 59 66 <span type="species:ncbi:9606">patient</span>
Diagram of the actin-Nrf2 signaling pathway in control and patient cells under basal conditions and during oxidative stress.
###end title 54
###begin p 55
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 363 364 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 383 384 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 385 386 385 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 842 843 842 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Under basal conditions, the Nrf2-Keap1 complex, or a sub-pool of it attached to the mitochondrial outer membrane by the PGAM5 protein, is bound to the actin stress filament network of control cells. B. In frataxin-depleted cells, characterized by abnormal iron handling, the actin-Nrf2 signaling pathway is profoundly altered by the need to cope with elevated H2O2 levels. Removing H2O2 with the catalase mimetic Euk134 corrects these alterations. C. Treating control cells with oligomycin or tBHQ results in major oxidative stress that destabilizes the actin-Nrf2-Keap1 complex, leading to Nrf2 release and phosphorylation. Nuclear translocation of Nrf2 results in the recruitment of the co-activator(s) needed for Phase II antioxidant transcription. D. In frataxin-depleted cells, the oxidative insult induced by oligomycin (endogenous) or tBHQ (exogenous) cannot be counterbalanced by the induction of Phase II antioxidants, so that the cells are extremely sensitive to oxidation. Again, Euk134 treatment restores the actin-Nrf2 signaling pathway, allowing transcription of Phase II antioxidants.
###end p 55
###begin title 56
Materials and Methods
###end title 56
###begin title 57
Cell culture
###end title 57
###begin p 58
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 118 126 <span type="species:ncbi:9606">Patients</span>
###xml 313 320 <span type="species:ncbi:9606">patient</span>
###xml 596 602 <span type="species:ncbi:9913">bovine</span>
Cultured fibroblasts derived from forearm biopsies were taken from four healthy controls and four patients with FRDA. Patients and controls gave their written informed consent to the biopsy procedure (this study was approved by the Conseil d'Ethique Biomedicale de l'Institut de Recherches Robert Debre/Ir2B). In patient fibroblasts, the GAA expansion in the first intron of the FRDA gene was larger than 2.1 kb on the shorter allele. The cells were grown under standard conditions in Dulbecco modified Eagle's medium (DMEM; Gibco, Invitrogen, Cergy Pontoise, France) supplemented with 10% fetal bovine serum, 10 g/ml penicillin/streptomycin, and 2 mM glutamine (Gibco Invitrogen). The medium was changed every three days.
###end p 58
###begin title 59
Cell survival experiment
###end title 59
###begin p 60
Cells were seeded in 6-well plates and grown to sub-confluence. The effect on the cells of four days' exposure to 30 microM of oligomycin was tested. The cells were counted after washing with PBS and trypsination, using a Quick Read Precision Cell slide (Globe Scientific Inc., Paramus, NJ).
###end p 60
###begin title 61
Enzyme assays
###end title 61
###begin p 62
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Bradford1">[51]</xref>
SOD activity was measured using a Cary 50 UV-visible spectrophotometer (Varian Inc, Les Ulis, France). Activities were determined by monitoring pyrogallol autooxidation at 420 nm and expressed as IU/mg protein. Protein concentrations were measured according to Bradford [51].
###end p 62
###begin title 63
Glutathione measurements
###end title 63
###begin p 64
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Tietze1">[52]</xref>
Glutathione levels were determined using a variant of the recycling enzymatic assay [52]. To estimate intracellular glutathione, total proteins were extracted with RIPA buffer. The assay reaction mixture was composed of cell extract, 20 mM DTNB, and 10 mM NADPH in 50 mM potassium phosphate buffer, pH 7.8. The reaction was started by adding glutathione reductase (1.5 units/ml), and the kinetics of DTNB conversion to TNB was followed spectrophotometrically at 412 nm. Glutathione concentrations were calculated from standard curves obtained with various concentrations of reduced glutathione (GSH) and oxidized glutathione (GSSG), based on the rates of TNB formation. For GSSG quantification, samples were pre-treated with 5% (v/v) 2-vinylpyridine for 1 hour at room temperature before analysis.
###end p 64
###begin title 65
Polarography
###end title 65
###begin p 66
###xml 283 287 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004253-Rustin6">[53]</xref>
Respiration of intact cells and oxidation of mitochondrial substrate (using 0.006% digitonin-permeabilized cells) were estimated using polarography, in a magnetically-stirred 250-microl cell thermostated at 37degreesC (DW1 Clark oxygen electrode; Hansatech Instruments; Norfolk, UK) [53]. All chemicals were of the purest grade available from Sigma-Aldrich (St Quentin; Falavier, France).
###end p 66
###begin title 67
Immunofluorescent staining
###end title 67
###begin p 68
###xml 186 190 <span type="species:ncbi:9925">goat</span>
###xml 491 497 <span type="species:ncbi:9986">rabbit</span>
###xml 506 511 <span type="species:ncbi:10090">mouse</span>
###xml 939 945 <span type="species:ncbi:9986">rabbit</span>
Fibroblasts washed with PBS were fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.1% Triton X-100 (w/v) for 5 min, and washed three times with PBS. After blocking with 5% goat serum in PBS/0.05% Tween (v/v) for 30 min, the cells were treated with anti-frataxin antibody, anti-Nrf2 antibody, anti-Keap1 antibody (all diluted 50-fold), or Alexa 568-conjugated phalloidin (diluted 250-fold), for 2 h. The cells were washed three times with PBS/0.05% Tween then treated with anti-rabbit or anti-mouse secondary antibody (diluted 500-fold) for 1 hour. The cells were then washed three times in PBS/0.05% Tween and mounted with fluorescent mounting medium (Dako, Trappes, France). All the procedures were carried out at room temperature. Antibodies to Nrf2 (H300), Keap1 (E-20), and frataxin (H-155) were purchased from Santa Cruz Biotechnology (Heidelberg, Germany). Alexa 568-conjugated phalloidin and Alexa 488-conjugated anti-rabbit secondary antibody were from Invitrogen (Cergy Pontoise, France). Fluorescent microscopy was performed using an LSM5 Exciter microscope (Zeiss; Le Pecq, France) and images were acquired using Axiovision software.
###end p 68
###begin title 69
###xml 27 28 27 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Treatment with oligomycin, tBHQ, and Euk134
###end title 69
###begin p 70
###xml 114 115 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 317 318 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 425 426 417 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 427 428 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Oxidative stress was induced by exposing the cells to oligomycin (30 microM; 18 h) or tertiary-butylhydroquinone (tBHQ) (100 microM; 20 h) (Sigma; St Quentin Falavier, France). The cells were then prepared for immunofluorescence staining or harvested for Western blot analysis or total RNA extraction. Oligomycin and tBHQ were diluted in ethanol. The final concentration of ethanol never exceeded 0.2%. To test for cellular H2O2 role in the FRDA cell phenotype, cells were treated with Euk134 (200 microM; 24 h) (Cayman Europe; Tallinn, Estonia) diluted in dimethyl sulfoxide (DMSO), whose final concentration did not exceed 0.1%.
###end p 70
###begin title 71
Western blot experiments
###end title 71
###begin p 72
The cytoplasmic and nuclear fractions of fibroblasts were obtained using the NXTRACT kit (Sigma-Aldrich; St Quentin Falavier, France), according to the manufacturer's instructions, except that lauryl-maltosyl (4 mM final concentration) was used as a detergent instead of IGEPAL-CA-630 during cell disruption. The protein concentration was assessed according to Bradford. Samples were heated for 5 min at 95degreesC with beta-mercapto-ethanol, and SDS PAGE Western blotting was performed using standard techniques. Either 40 or 60 microg of protein was loaded on 10% acrylamide gel then transferred to a PVDF membrane (Biorad, Marnes-la-Coquette, France). The membranes were blocked in 5% skim milk in PBS/0.05% Tween and incubated overnight with primary antibodies, at 4degreesC). Anti-GAPDH (ab8245) and anti-histone H1 (ab11079) antibodies were purchased from Abcam (Paris, France). HRP secondary antibodies (1 h RT) were revealed by ECL (Amersham Pharmacia Biotech, Amersham, UK). Densitometric measures were performed with Image J software.
###end p 72
###begin title 73
Q-PCR experiments
###end title 73
###begin p 74
###xml 286 288 280 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm</sup>
###xml 917 921 865 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1062 1085 1010 1033 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GGTGAAAAGGACCCCACGA3&#8242;</named-content>
###xml 1090 1115 1038 1063 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TCAAGGGCATATCCTACAACA3&#8242;</named-content>
###xml 1123 1148 1071 1096 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CATTCTGAAAGGCTGGTTTGA3&#8242;</named-content>
###xml 1152 1176 1100 1124 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TTGCAGAGAGTACATGGAGC3&#8242;</named-content>
###xml 1184 1209 1132 1157 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TTGGGCAAAGGTGGAAATGAA3&#8242;</named-content>
###xml 1213 1237 1161 1185 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CACCACAAGCCAAACGACTT3&#8242;</named-content>
###xml 1245 1270 1193 1218 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GGACAAACCTCAGCCCTAACG3&#8242;</named-content>
###xml 1275 1300 1223 1248 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TTTGATGGCTTCCAGCAACTC3&#8242;</named-content>
###xml 1309 1332 1257 1280 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GCAGGAGGGCTCACTCAAA3&#8242;</named-content>
###xml 1337 1361 1285 1309 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;AGGTGACGCAGGATGGTATT3&#8242;</named-content>
###xml 1369 1393 1317 1341 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TGCTGTCTTGCAGGGAATGT3&#8242;</named-content>
###xml 1398 1421 1346 1369 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CACAACCATCCACCACTGC3&#8242;</named-content>
###xml 1433 1457 1381 1405 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GTCTGTGTGAGAACATTGCC3&#8242;</named-content>
###xml 1462 1485 1410 1433 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;ATGTGGCTCCCGTAGTCAG3&#8242;</named-content>
###xml 1510 1534 1458 1482 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;ATCCCAACTGTGGTCTTCAG3&#8242;</named-content>
###xml 1539 1565 1487 1513 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CACGTTGAATAGGTC TTCACA3&#8242;</named-content>
###xml 1581 1604 1529 1552 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCCAGGCTCTCTAGATGAG3&#8242;</named-content>
###xml 1609 1633 1557 1581 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GTCCAGTCATAACGCTTAGG3&#8242;</named-content>
Total RNA was extracted from fibroblasts using the RNeasy(R)Mini Kit (Qiagen; Courtaboeuf, France) and cDNA was obtained from 1 microg RNA using the RNA PCR Core kit (Roche; Neuilly sur Seine, France) according to the manufacturer's instructions. Quantitative PCR was performed using IQtmSYBR(R) Green supermix and the MyIQ Single-Color Real-Time PCR Detection System (Biorad). Amplification was achieved using 3 minutes' denaturation at 95degreesC, 45 denaturation cycles at 96degreesC for 20 s, annealing at 60degreesC for 20 s, elongation at 72degreesC for 20 s, melting at 95degreesC for 1 min then 55degreesC for 1 min, and heating to 95degreesC. RNA was used as the template for the negative-control amplifications included in each PCR run. All reactions were performed in triplicate, and PCR runs were repeated twice. Data were analyzed using MyIQ(R) software. The amount of target mRNA was normalized for the HPRT gene mRNA. Primer pairs were designed to be 20 bp in various exons and to generate products of about 100 bp. Primers were as follows: HPRT, 5'GGTGAAAAGGACCCCACGA3' and 5'TCAAGGGCATATCCTACAACA3'; NQO1, 5'CATTCTGAAAGGCTGGTTTGA3'and 5'TTGCAGAGAGTACATGGAGC3'; SOD1, 5'TTGGGCAAAGGTGGAAATGAA3'and 5'CACCACAAGCCAAACGACTT3'; SOD2, 5'GGACAAACCTCAGCCCTAACG3' and 5'TTTGATGGCTTCCAGCAACTC3'; GSTP1, 5'GCAGGAGGGCTCACTCAAA3' and 5'AGGTGACGCAGGATGGTATT3'; GCLC, 5'TGCTGTCTTGCAGGGAATGT3' and 5'CACAACCATCCACCACTGC3'; catalase, 5'GTCTGTGTGAGAACATTGCC3' and 5'ATGTGGCTCCCGTAGTCAG3'; glutathione reductase, 5'ATCCCAACTGTGGTCTTCAG3' and 5'CACGTTGAATAGGTC TTCACA3'; and frataxin, 5'CCCAGGCTCTCTAGATGAG3' and 5'GTCCAGTCATAACGCTTAGG3'.
###end p 74
###begin title 75
Short hairpin RNA experiments
###end title 75
###begin p 76
###xml 385 442 376 433 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCGGGCTGGACTCTTTAGCAGAGTTCTCGAGAACTCTGCTAAAGAGTCCAGCTTTTT</named-content>
Neuroblastoma-derived SKNAS cells were used after frataxin silencing by short hairpin RNA (shRNA). In brief, frataxin-depleted SKNAS cells were obtained by transducing lentiviral particles carrying a gene encoding frataxin-directed shRNA and a puromycin resistance cassette (MISSIONtrade mark TRC shRNA; Sigma-Aldrich, St Louis, Missouri). The frataxin-targeting sequence of shRNA was CCGGGCTGGACTCTTTAGCAGAGTTCTCGAGAACTCTGCTAAAGAGTCCAGCTTTTT. SKNAS cells were seeded in 24-well plates. After 24 h, 2 microg/ml hexadimethrine bromide was added just before infection with lentiviral particles. After 18 h, the cells were washed three times with PBS. Successfully infected cells were selected using 10 microg/ml of puromycin (15 d).
###end p 76
###begin title 77
Statistical analysis
###end title 77
###begin p 78
Data are reported as means+/-SEM. Statistical tests were run using Statview software (SAS, Cary, NC). ANOVA was performed, followed by Student's test.
###end p 78
###begin title 79
Supporting Information
###end title 79
###begin p 80
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Samples were loaded as following: controls (lanes 1, 2 and 3), patients (lane 4, 5 and 6), purified Grx2 (lane 7). alpha-actin was used as a loading control.
###end p 80
###begin p 81
(2.18 MB TIF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 72 79 <span type="species:ncbi:9606">patient</span>
###xml 105 112 <span type="species:ncbi:9606">patient</span>
Effect of iron chelators and Euk134 on Nrf2 localization in control and patient fibroblasts. Control and patient cells were exposed 24 h either to Deferiprone, Desferoxamine or Euk134. Results reflect percentage of cells showing actin-bound Nrf2.
###end p 83
###begin p 84
(0.04 MB DOC)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
Supplemental Experimental Procedures and figure legend
###end p 86
###begin p 87
(0.03 MB DOC)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin title 89
References
###end title 89
###begin article-title 90
Mitochondria, from cell death to proliferation.
###end article-title 90
###begin article-title 91
Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space.
###end article-title 91
###begin article-title 92
Redox pathways of the mitochondrion.
###end article-title 92
###begin article-title 93
Free radicals in the physiological control of cell function.
###end article-title 93
###begin article-title 94
Radicals r'aging.
###end article-title 94
###begin article-title 95
Disabled early recruitment of antioxidant defenses in Friedreich's ataxia.
###end article-title 95
###begin article-title 96
The use of antioxidants in Friedreich's ataxia treatment.
###end article-title 96
###begin article-title 97
###xml 13 35 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Reduction of Caenorhabditis elegans frataxin increases sensitivity to oxidative stress, reduces lifespan, and causes lethality in a mitochondrial complex II mutant.
###end article-title 97
###begin article-title 98
###xml 40 50 <span type="species:ncbi:7227">Drosophila</span>
Causative role of oxidative stress in a Drosophila model of Friedreich ataxia.
###end article-title 98
###begin article-title 99
Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia.
###end article-title 99
###begin article-title 100
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
###end article-title 100
###begin article-title 101
Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features.
###end article-title 101
###begin article-title 102
Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.
###end article-title 102
###begin article-title 103
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes.
###end article-title 103
###begin article-title 104
Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.
###end article-title 104
###begin article-title 105
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins.
###end article-title 105
###begin article-title 106
Functional studies of frataxin.
###end article-title 106
###begin article-title 107
Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases.
###end article-title 107
###begin article-title 108
The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.
###end article-title 108
###begin article-title 109
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease.
###end article-title 109
###begin article-title 110
###xml 68 73 <span type="species:ncbi:4932">yeast</span>
Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
###end article-title 110
###begin article-title 111
Manganese superoxide dismutase induction by iron is impaired in Friedreich ataxia cells.
###end article-title 111
###begin article-title 112
The mtDNA NARP mutation activates the actin-Nrf2 signaling of antioxidant defenses.
###end article-title 112
###begin article-title 113
Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.
###end article-title 113
###begin article-title 114
Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.
###end article-title 114
###begin article-title 115
Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury.
###end article-title 115
###begin article-title 116
###xml 23 26 <span type="species:ncbi:10116">rat</span>
Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1.
###end article-title 116
###begin article-title 117
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human glutaredoxin 2 as iron-sulfur protein: a possible role as redox sensor.
###end article-title 117
###begin article-title 118
###xml 67 72 <span type="species:ncbi:9606">human</span>
How does iron-sulfur cluster coordination regulate the activity of human glutaredoxin 2?
###end article-title 118
###begin article-title 119
Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA.
###end article-title 119
###begin article-title 120
A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy.
###end article-title 120
###begin article-title 121
Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress.
###end article-title 121
###begin article-title 122
ATP-induced inhibition of mitochondrial ATPase by oligomycin.
###end article-title 122
###begin article-title 123
Production of reactive oxygen species due to metabolic activation of butylated hydroxyanisole.
###end article-title 123
###begin article-title 124
Differential activation of the PI 3-kinase effectors AKT/PKB and p70 S6 kinase by compound 48/80 is mediated by PKCalpha.
###end article-title 124
###begin article-title 125
Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2.
###end article-title 125
###begin article-title 126
###xml 73 76 <span type="species:ncbi:10116">rat</span>
EUK-134, a synthetic superoxide dismutase and catalase mimetic, protects rat kidneys from ischemia-reperfusion-induced damage.
###end article-title 126
###begin article-title 127
###xml 62 72 <span type="species:ncbi:7227">Drosophila</span>
Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia.
###end article-title 127
###begin article-title 128
Friedreich ataxia: the oxidative stress paradox.
###end article-title 128
###begin article-title 129
Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress.
###end article-title 129
###begin article-title 130
Deferiprone targets aconitase: implication for Friedreich's ataxia treatment.
###end article-title 130
###begin article-title 131
Quinone analogs prevent enzymes targeted in Friedreich ataxia from iron-induced injury in vitro.
###end article-title 131
###begin article-title 132
###xml 49 54 <span type="species:ncbi:4932">yeast</span>
Oxidative stress and protease dysfunction in the yeast model of Friedreich ataxia.
###end article-title 132
###begin article-title 133
Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin.
###end article-title 133
###begin article-title 134
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 98 103 <span type="species:ncbi:4932">yeast</span>
The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast.
###end article-title 134
###begin article-title 135
PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria.
###end article-title 135
###begin article-title 136
Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study.
###end article-title 136
###begin article-title 137
###xml 144 159 <span type="species:ncbi:10090">transgenic mice</span>
The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
###end article-title 137
###begin article-title 138
###xml 72 87 <span type="species:ncbi:10090">transgenic mice</span>
Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist.
###end article-title 138
###begin article-title 139
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
###end article-title 139
###begin article-title 140
Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.
###end article-title 140
###begin article-title 141
Biochemical and molecular investigations in respiratory chain deficiencies.
###end article-title 141
###begin p 142
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 142
###begin p 143
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 54 61 <span type="species:ncbi:9606">patient</span>
Funding: This work was supported by Friedreich ataxia patient organizations in France (AFAF and REVAmoto), Switzerland (ACHAF), and the US (FARA). EPD and PR were supported by the European Community sixth Framework Program for Research, contract number LSHM-CT-2004-503116; EPD and PR by the Leducq foundation; SG, V, and PR by the ANR MRAR Friedreich project; and PR by the AFM (Association Francaise contre les Myopathies) and AMMi (Association contre les Maladies Mitochondriales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 143

